Synamatix Announces Licensing of SynaBASE to Washington University
News Apr 05, 2006
Synamatix has announced that Washington University Genome Sequencing Center (WUGSC) has licensed SynaBASE™ and associated applications for use in high-throughput genomic analysis for internal research projects.
The Center will also apply selected Synamatix applications towards enhancing quality control of data from newly sequenced genomes.
The SynaBASE database platform is a novel approach towards enhancing the scalability, sensitivity and performance of genomics research without necessarily requiring incremental utilization of specialist computer hardware.
Dr. Jarret Glasscock, who heads the computational biology group at WUGSC stated, “We are excited about the potential of applying SynaBASE towards our larger scale tasks as well as addressing some novel areas which take advantage of the SynaBASE approach.”
Dr. Arif Anwar, Vice President of Synamatix said, “It is particularly encouraging to welcome WUGSC as a partner and user as they have identified numerous additional applications for the SynaBASE platform. We are looking forward to developing a mutually beneficial partnership which can deliver tangible advances in genome research.”
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE
Artificial Cellular Compartments BuiltNews
How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.READ MORE